These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 38256379)

  • 1. Changes in Circulating Acylated Ghrelin and Neutrophil Elastase in Diabetic Retinopathy.
    Trotta MC; Gesualdo C; Russo M; Lepre CC; Petrillo F; Vastarella MG; Nicoletti M; Simonelli F; Hermenean A; D'Amico M; Rossi S
    Medicina (Kaunas); 2024 Jan; 60(1):. PubMed ID: 38256379
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevalence of diabetic retinopathy, proliferative diabetic retinopathy and non-proliferative diabetic retinopathy in Asian T2DM patients: a systematic review and Meta-analysis.
    Yang QH; Zhang Y; Zhang XM; Li XR
    Int J Ophthalmol; 2019; 12(2):302-311. PubMed ID: 30809489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Association of choroidal thickness with diabetic retinopathy at different stages].
    Wang S; Lin S; Zheng Y; Di F; Cao X; Liu C; Yang J
    Zhonghua Yi Xue Za Zhi; 2015 Aug; 95(32):2584-8. PubMed ID: 26711604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction Between the Distribution of Diabetic Retinopathy Lesions and the Association of Optical Coherence Tomography Angiography Scans With Diabetic Retinopathy Severity.
    Ashraf M; Sampani K; Rageh A; Silva PS; Aiello LP; Sun JK
    JAMA Ophthalmol; 2020 Dec; 138(12):1291-1297. PubMed ID: 33119083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic and prognostic role of serum miR-20b, miR-17-3p, HOTAIR, and MALAT1 in diabetic retinopathy.
    Shaker OG; Abdelaleem OO; Mahmoud RH; Abdelghaffar NK; Ahmed TI; Said OM; Zaki OM
    IUBMB Life; 2019 Mar; 71(3):310-320. PubMed ID: 30468285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum Iba-1, GLUT5, and TSPO in Patients With Diabetic Retinopathy: New Biomarkers for Early Retinal Neurovascular Alterations? A Pilot Study.
    Trotta MC; Gesualdo C; Petrillo F; Cavasso G; Corte AD; D'Amico G; Hermenean A; Simonelli F; Rossi S
    Transl Vis Sci Technol; 2022 Mar; 11(3):16. PubMed ID: 35285861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inner retinal oxygen delivery and metabolism in progressive stages of diabetic retinopathy.
    Rahimi M; Hossain F; Leahy S; Blair NP; Jiang X; Shahidi M
    Sci Rep; 2024 Feb; 14(1):4414. PubMed ID: 38388657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum and vitreous levels of visfatin in patients with diabetic retinopathy.
    Wang Y; Yuan Y; Jiang H
    Med Sci Monit; 2014 Dec; 20():2729-32. PubMed ID: 25524991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic value of peripheral retinal nonperfusion in diabetic retinopathy using ultra-widefield fluorescein angiography.
    Antaki F; Coussa RG; Mikhail M; Archambault C; Lederer DE
    Graefes Arch Clin Exp Ophthalmol; 2020 Dec; 258(12):2681-2690. PubMed ID: 32676792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum erythropoietin concentration and its correlation with stage of diabetic retinopathy.
    Davidović S; Babić N; Jovanović S; Barišić S; Grković D; Miljković A
    BMC Ophthalmol; 2019 Nov; 19(1):227. PubMed ID: 31727007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of fenofibrate on inflammatory cytokines in diabetic retinopathy patients.
    Ju HB; Zhang FX; Wang S; Song J; Cui T; Li LF; Zhang HY
    Medicine (Baltimore); 2017 Aug; 96(31):e7671. PubMed ID: 28767589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitreous fluid and circulating levels of soluble lr11, a novel marker for progression of diabetic retinopathy.
    Shiba T; Bujo H; Takahashi M; Sato Y; Jiang M; Hori Y; Maeno T; Shirai K
    Graefes Arch Clin Exp Ophthalmol; 2013 Dec; 251(12):2689-95. PubMed ID: 23652469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumour necrosis factor α-308 G/a and -238 G/a polymorphisms as predicator of diabetic retinopathy in Egyptians.
    Moemen LAAA; El Shahat Ebeid M; A Abdelazeem A; Kenawy M Kenawy M; M Osman Z
    Arch Physiol Biochem; 2023 Oct; 129(5):1143-1151. PubMed ID: 33910435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy.
    Perais J; Agarwal R; Evans JR; Loveman E; Colquitt JL; Owens D; Hogg RE; Lawrenson JG; Takwoingi Y; Lois N
    Cochrane Database Syst Rev; 2023 Feb; 2(2):CD013775. PubMed ID: 36815723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteome Changes Associated with the VEGFR Pathway and Immune System in Diabetic Macular Edema Patients at Different Diabetic Retinopathy Stages.
    Han R; Gong R; Liu W; Xu G
    Curr Eye Res; 2022 Jul; 47(7):1050-1060. PubMed ID: 35435079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pan-retinal photocoagulation and other forms of laser treatment and drug therapies for non-proliferative diabetic retinopathy: systematic review and economic evaluation.
    Royle P; Mistry H; Auguste P; Shyangdan D; Freeman K; Lois N; Waugh N
    Health Technol Assess; 2015 Jul; 19(51):v-xxviii, 1-247. PubMed ID: 26173799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of serum NO, TNF-alpha, IL-1beta, sIL-2R, IL-6 and IL-8 levels with grades of retinopathy in patients with diabetes mellitus.
    Doganay S; Evereklioglu C; Er H; Türköz Y; Sevinç A; Mehmet N; Savli H
    Eye (Lond); 2002 Mar; 16(2):163-70. PubMed ID: 11988817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinically Significant Nonperfusion Areas on Widefield OCT Angiography in Diabetic Retinopathy.
    Kawai K; Murakami T; Mori Y; Ishihara K; Dodo Y; Terada N; Nishikawa K; Morino K; Tsujikawa A
    Ophthalmol Sci; 2023 Mar; 3(1):100241. PubMed ID: 36545265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of laser photocoagulation on serum angiopoietin-1, angiopoietin-2, angiopoietin-1/angiopoietin-2 ratio, and soluble angiopoietin receptor Tie-2 levels in type 2 diabetic patients with proliferative diabetic retinopathy.
    You QY; Zhuge FY; Zhu QQ; Si XW
    Int J Ophthalmol; 2014; 7(4):648-53. PubMed ID: 25161936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TGF-β Serum Levels in Diabetic Retinopathy Patients and the Role of Anti-VEGF Therapy.
    Bonfiglio V; Platania CBM; Lazzara F; Conti F; Pizzo C; Reibaldi M; Russo A; Fallico M; Ortisi E; Pignatelli F; Longo A; Avitabile T; Drago F; Bucolo C
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33334029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.